BRCA2 and neoplasm: Secondly, it will examine the clinical implications of the interactions between BRCA1, and to a lesser extent BRCA2 PVs, the tumour microenvironment, and epigenetic regulation in terms of prognosis and treatment for hereditary breast cancer.